Centrum Medyczne ENEL-MED Balance Sheet Health
Financial Health criteria checks 3/6
Centrum Medyczne ENEL-MED has a total shareholder equity of PLN163.7M and total debt of PLN26.1M, which brings its debt-to-equity ratio to 15.9%. Its total assets and total liabilities are PLN518.1M and PLN354.4M respectively. Centrum Medyczne ENEL-MED's EBIT is PLN9.7M making its interest coverage ratio 0.6. It has cash and short-term investments of PLN33.6M.
Key information
15.9%
Debt to equity ratio
zł26.10m
Debt
Interest coverage ratio | 0.6x |
Cash | zł33.59m |
Equity | zł163.70m |
Total liabilities | zł354.38m |
Total assets | zł518.08m |
Recent financial health updates
Is Centrum Medyczne ENEL-MED (WSE:ENE) A Risky Investment?
Jun 09We Think Centrum Medyczne ENEL-MED (WSE:ENE) Can Stay On Top Of Its Debt
Feb 01Recent updates
Centrum Medyczne ENEL-MED's (WSE:ENE) Solid Earnings Are Supported By Other Strong Factors
May 30Calculating The Fair Value Of Centrum Medyczne ENEL-MED S.A. (WSE:ENE)
Apr 21Centrum Medyczne ENEL-MED's (WSE:ENE) Returns On Capital Not Reflecting Well On The Business
May 12Is Centrum Medyczne ENEL-MED (WSE:ENE) A Risky Investment?
Jun 09Is There More Growth In Store For Centrum Medyczne ENEL-MED's (WSE:ENE) Returns On Capital?
Feb 22We Think Centrum Medyczne ENEL-MED (WSE:ENE) Can Stay On Top Of Its Debt
Feb 01We Think Centrum Medyczne ENEL-MED's (WSE:ENE) Statutory Profit Might Understate Its Earnings Potential
Jan 11Can Mixed Fundamentals Have A Negative Impact on Centrum Medyczne ENEL-MED S.A. (WSE:ENE) Current Share Price Momentum?
Dec 21Does Centrum Medyczne ENEL-MED's (WSE:ENE) Share Price Gain of 92% Match Its Business Performance?
Nov 30Financial Position Analysis
Short Term Liabilities: ENE's short term assets (PLN83.6M) do not cover its short term liabilities (PLN137.9M).
Long Term Liabilities: ENE's short term assets (PLN83.6M) do not cover its long term liabilities (PLN216.5M).
Debt to Equity History and Analysis
Debt Level: ENE has more cash than its total debt.
Reducing Debt: ENE's debt to equity ratio has reduced from 49.5% to 15.9% over the past 5 years.
Debt Coverage: ENE's debt is well covered by operating cash flow (338.4%).
Interest Coverage: ENE's interest payments on its debt are not well covered by EBIT (0.6x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/23 22:11 |
End of Day Share Price | 2024/12/23 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Centrum Medyczne ENEL-MED S.A. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Sylwia Jaskiewicz | Dom Maklerski Banku Ochrony Srodowiska S.A. |
Adrian Kowollik | Dr. Kalliwoda Research |
Adrian Kowollik | East Value Research GmbH |